Keishibukuryogan Reduces Inflammation in Skin Cells
Author Information
Author(s): Yoshihisa Yoko, Furuichi Megumi, Ur Rehman Mati, Ueda Chieko, Makino Teruhiko, Shimizu Tadamichi
Primary Institution: University of Toyama
Hypothesis
Does Keishibukuryogan inhibit the production of inflammatory cytokines in human dermal endothelial cells?
Conclusion
Keishibukuryogan significantly suppresses the production of inflammatory cytokines in LPS-stimulated human dermal endothelial cells.
Supporting Evidence
- KBG treatment significantly suppressed mRNA levels of inflammatory cytokines.
- Paeoniflorin also inhibited the production of inflammatory cytokines.
- KBG and paeoniflorin decreased the expression of COX-2 and iNOS.
Takeaway
Keishibukuryogan, a traditional Japanese medicine, helps reduce inflammation in skin cells, which could be good for treating certain skin diseases.
Methodology
The study used human dermal microvessel endothelial cells treated with lipopolysaccharide and either Keishibukuryogan or paeoniflorin to measure cytokine production.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website